<DOC>
	<DOCNO>NCT01102543</DOCNO>
	<brief_summary>The aim Aliz√© describe population premature baby ( gestational age ( GA ) &lt; 32 week ) real life situation management RDS .</brief_summary>
	<brief_title>Observational Study Prophylactic Use Curosurf Neonatal Respiratory Distress Syndrome ( RDS )</brief_title>
	<detailed_description>Description include gestational age , birth clinical characteristic particular respiratory function , evaluation mother prenatal corticosteroid treatment prophylaxis RDS , mother medical obstetric history , premature baby care delivery room special focus Curosurf use : prophylactic curative use / surfactant / surfactant . A special focus Prophylactic use .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Hyaline Membrane Disease</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<criteria>study , neonatologist include baby bear gestational age &lt; 32 GA gestational age &gt; 32 GA No consent data collection one parent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Hours</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>pulmonary surfactant</keyword>
	<keyword>Respiratory distress syndrome</keyword>
	<keyword>Newborn</keyword>
	<keyword>prophylaxis</keyword>
</DOC>